. Lifelancer ( ) is a talent-hiring platform in Life Sciences, Pharma and IT. The platform connects talent with opportunities... in pharma, biotech, health sciences, healthtech and IT domains. For more details and to find similar roles, please check out...
) Lifelancer ( ) is a talent-hiring platform in Life Sciences, Pharma and IT. The platform connects talent with opportunities... in pharma, biotech, health sciences, healthtech and IT domains. For more details and to find similar roles, please check out...
Job Title: Biotech/Pharma Key Account Manager Job Location: United States Job Location Type: Remote Job Contract...? As a Biotech/Pharma Key Account Manager, you get to work with an astonishing team that plays a vital role at ZEISS. Show case...
authorization in the United States. Sales Lifelancer ( ) is a talent-hiring platform in Life Sciences, Pharma and IT. The... platform connects talent with opportunities in pharma, biotech, health sciences, healthtech and IT domains...
and apply today! Lifelancer ( ) is a talent-hiring platform in Life Sciences, Pharma and IT. The platform connects talent with opportunities... in pharma, biotech, health sciences, healthtech and IT domains. For more details and to find similar roles, please check out...
Mumbai-based payments solution provider, Seshaasai Technologies filed its initial draft papers with SEBI on December 27. The company is offering a combination of fresh issue and offer-for-sale in the upcoming IPO. Continue Reading »
Anand Rathi Investment Services recommends Escorts Kubota shares as its pick for December. The brokerage sees an 11.55 per cent upside for the stock. Continue Reading »
Expert View: Dr Mohit Batra, Founder of MarketsMojo believes 2025 will likely present a more challenging investment landscape and investors must adopt a long-term perspective amid bouts of market volatility. Continue Reading »
Multibagger stock to buy now: Ventura Securities has given a ‘buy’ tag to Adani Energy Solutions shares predicting a two-year target of ₹1696 apiece Continue Reading »
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Can Fin Homes, Dr Reddy's Laboratories, and Mahindra & Mahindra Continue Reading »
India's IPO market reached a record $11.2 billion in 2024, doubling from $5.5 billion in 2023, driven by retail participation and domestic inflows. Some of the key listings included Hyundai Motor and Swiggy. Continue Reading »